Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 11,346	$ 9,341	$ 22,290	$ 18,627
General and administrative	4,977	3,668	9,911	7,430
Total operating expenses	16,323	13,009	32,201	26,057
Operating Income (Loss), Total	(16,323)	(13,009)	(32,201)	(26,057)
Interest income	408	47	516	101
Interest Expense	(272)	0	(526)	0
Net loss	$ (16,187)	$ (12,962)	$ (32,211)	$ (25,956)
Net loss per common share, basic	$ (0.25)	$ (0.25)	$ (0.52)	$ (0.50)
Net loss per common share, Diluted	$ (0.25)	$ (0.25)	$ (0.52)	$ (0.50)
Weighted-average shares used to compute net loss per common share, Basic	64,279,634	51,904,701	62,465,092	51,483,709
Weighted-average shares used to compute net loss per common share, Diluted	64,279,634	51,904,701	62,465,092	51,483,709